Rhenman & Partners Asset Management’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-10,000
| Closed | -$1.4M | – | 101 |
|
|
2018
Q4 | $1.4M | Sell |
10,000
-40,000
| -80% | -$5.6M | 0.16% | 68 |
|
|
2018
Q3 | $8.54M | Sell |
50,000
-72,961
| -59% | -$12.5M | 0.86% | 51 |
|
|
2018
Q2 | $21.3M | Buy |
122,961
+47,961
| +64% | +$8.32M | 2.18% | 16 |
|
|
2018
Q1 | $8.65M | Sell |
75,000
-15,280
| -17% | -$1.76M | 1.07% | 42 |
|
|
2017
Q4 | $7.6M | Buy |
90,280
+15,280
| +20% | +$1.29M | 1.03% | 37 |
|
|
2017
Q3 | $6.91M | Buy |
+75,000
| New | +$6.91M | 0.88% | 43 |
|